CD133(+) TICs have an elevated level of MYC IRES activity, indicating that MSI2High cells supported increased levels of MYC protein synthesis through IRES-initiated, cap-independent translation to meet an adverse tumor microenvironment (Fig. 3F). Here, MYC is linked to neoplasm.